Chemosensitivity and Endocrine Sensitivity Predicted by MammaPrint and BluePrint in the Prospective Neoadjuvant Breast Registry Symphony Trial

Authors

• Mark A. Gittleman MD, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

4-2014

Volume

21

Issue

2

Published In/Presented At

2014 Annual Meeting Official Proceedings, Volume XV. Ann Surg Oncol 21 (Suppl 2), 199–344 (2014). https://doi.org/10.1245/s10434-014-3672-z

Disciplines

Medicine and Health Sciences

Department(s)

Department of Surgery

Document Type

Article